TW

Timothy Wright

General Partner at TIME BioVentures

San Diego County, California

Overview 

Timothy Wright is a Venture Investor and Consultant with a background as General Partner at TIME BioVentures and experience as Chief Research and Development Officer at Regulus Therapeutics. He holds a Doctor of Medicine from The Johns Hopkins University School of Medicine and has served in executive roles at various biotech and pharmaceutical companies. Wright has a strong track record in clinical development and pharmaceutical industry, having held positions such as Global Head of Translational Sciences at Novartis and Executive Vice President of Translational Sciences at California Institute for Biomedical Research.

Work Experience 

TIME BioVentures

  • General Partner

    2019 - Current

GX Molecular Inc

  • Interim CEO

    2023 - 2024

KB

Kling Biotherapeutics

  • Interim CEO

    2021 - 2022

RT

Regulus Therapeutics

  • Chief Research and Development Officer

    2016 - 2019

Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

Raised $480,899,992.00 from New Enterprise Associates, Vivo Capital, Octagon Capital Advisors, Federated Hermes, Deep Track Capital, Adage Capital Management, RA Capital Management, Federated Kaufmann Fund, New Enterprise Associates and New Enterprise Associates.

regulusrx.com
CI

California Institute for Biomedical Research

  • Executive Vice President, Translational Sciences

    2015 - 2016

N

Novartis

  • Global Head, Pharma Development

    2011 - 2015

    Late stage drug development (small molecule and biologics) from proof of concept through commercialization.

  • Senior Vice President, Global Head of Translational Sciences

    2007 - 2011

    Translational Sciences included Translational Medicine, Toxicology, Drug Metabolism & Pharmacokinetics, Clinical Operations, Biomarker Development, Program Strategy, and Clinical Sourcing

  • Vice President, Global Head of Translational Medicine

    2006 - 2007

    Early stage clinical programs (small molecule and biologics) through Proof of Concept in humans.

  • Vice President, Exploratory Clinical Development

    2004 - 2006

    Deputy Head for Translational Research responsible for early clinical testing in Immunology, Dermatology, Respiratory, Gastrointestinal, and Musculoskeletal Therapeutic Areas.

P

Pfizer

  • Senior Director

    2001 - 2004

    Exploratory Development - Inflammation Research Pharmacology - Inflammation

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

pfizer.com
Uo

University of Pittsburgh

  • Assistant/Associate Professor (tenured)/Division Chief

    1991 - 2001

    Division of Rheumatology and Clinical Immunology Department of Molecular Genetics and Biochemistry (Graduate Appointment) Basic Research Clinical Research Clinical Medicine Teaching (Undergraduate, Medical and Graduate Students) Endowed Professor Administration

JH

Johns Hopkins University

  • Postdoctoral Fellow/Instructor/Assistant Professor

    1983 - 1985

    Division of Molecular and Clinical Rheumatology Department of Molecular Biology & Genetics Basic Research Clinical Research Teaching (undergraduate, Medical and Graduate Students) Clinical Medicine

Education 

Articles About Timothy

Relevant Websites